Tim Boreham

Experts

CRITERION: Catch a falling Star?

October 13, 2023October 13, 2023 | Tim Boreham

Experts

CRITERION: Do these ASX plays of the day deserve a sporting chance?

October 6, 2023October 5, 2023 | Tim Boreham

Experts

Dr Boreham’s Crucible: With a US focus, can Next Science’s new leaders stem the bleeding?

October 2, 2023October 1, 2023 | Tim Boreham

Experts

CRITERION: Divvies are down… but still better than what you’ll get from the banks

September 29, 2023November 26, 2023 | Tim Boreham

Experts

CRITERION: A beaten up uranium stock at 1/10th the average resource value? That’s a glowing recommendation

September 21, 2023September 20, 2023 | Tim Boreham

Experts

Dr Boreham’s Crucible: The path to a US$10bn market by 2026 is clear for Clarity

September 19, 2023September 20, 2023 | Tim Boreham

Experts

CRITERION: Save it for a rainy day with these ASX storage stocks

September 15, 2023September 14, 2023 | Tim Boreham

Experts

Dr Boreham’s Crucible: Is this the only POTUS-approved ASX AI play?

September 2, 2023September 4, 2023 | Tim Boreham

Experts

CRITERION: Cracking the China nut – it’s the GOAT challenge

September 1, 2023September 1, 2023 | Tim Boreham

Experts

CRITERION: The good oil on crude? It’s not dead yet

August 17, 2023August 16, 2023 | Tim Boreham

Experts

CRITERION: Lift-off on the ASX in 2023? It’s Too Bloody ‘Ard!

August 10, 2023August 9, 2023 | Tim Boreham

Experts

Dr Boreham’s Crucible: Oh, Mesoblast! You were the Chosen One!

August 7, 2023August 6, 2023 | Tim Boreham